C‐reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype‐based analysis
- 1 August 2004
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (8) , 1240-1243
- https://doi.org/10.1111/j.1538-7836.2004.00773.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- C-reactive protein and risk of cardiovascular disease: Evidence and clinical applicationCurrent Atherosclerosis Reports, 2003
- Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)The American Journal of Medicine, 2002
- Partition-Ligation–Expectation-Maximization Algorithm for Haplotype Inference with Single-Nucleotide PolymorphismsAmerican Journal of Human Genetics, 2002
- Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP geneGenes & Immunity, 2002
- Human C-reactive protein (CRP) 1059G/C polymorphismJournal of Human Genetics, 2000
- Predictors of Survival After Deep Vein Thrombosis and Pulmonary EmbolismArchives of internal medicine (1960), 1999
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Acute phase response and deep lower limb venous thrombosis.Journal of Clinical Pathology, 1990
- Liquid crystal thermography and C reactive protein in the detection of deep venous thrombosis.BMJ, 1989
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989